Concern noted.
All we know is based on historical data onclosed markets with only the early adopters mainly not concerned with cost but wanting to retain their status as the best Cancer Centers/facilities. Evidence low churn % and albeit slow but continual uptake and increasing testing during those conditions.
Does Australia market offer insight to how good the product is by paying upfront and no reimbursement. NSW Health has over 50 SOZOs (since Q4 2021) I have not confirmed myself how much that cost is. Even in my area Lymphedema therapist have SOZOs.
Saas model is constructed that the USA facilities can make money( not pay out money which is the standard SaaS model) and have better patient outcomes. This market has only really opened up 2024. That Michigan contract starting at $2500 from first month hints model will work. I also liked when Dr Bains said they were showcasing how the successful facilities (21% of sites) are running LPP to the potential facilities. UoK and Baylor, Scott & White are large users of SOZO since 2021.
I can say more but will keep this one brief.
There is a better way.
Acclivity
Concern noted.All we know is based on historical data onclosed...
Add IPD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.9¢ |
Change
0.003(3.49%) |
Mkt cap ! $180.0M | |||
| Open | High | Low | Value | Volume |
| 8.6¢ | 8.9¢ | 8.3¢ | $123.6K | 1.451M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 480587 | 8.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.9¢ | 14999 | 1 |
View Market Depth
| Last trade - 16.10pm 29/04/2024 (20 minute delay) ? |
|
|||||
|
Last
8.5¢ |
Change
0.003 ( 2.07 %) |
||||
| Open | High | Low | Volume | ||
| 8.6¢ | 8.8¢ | 8.3¢ | 703656 | ||
| Last updated 15.59pm 29/04/2024 ? | |||||
| IPD (ASX) Chart |